- Investing Ideas
- /
- South Korean Healthcare Undervalued Stocks Based On Cash Flows
South Korean Healthcare Undervalued Stocks Based On Cash Flows
Results
3
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
DuChemBIOLtd
Market Cap: ₩281.2b
Engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea.
A176750
₩9,920.00
7D
7.8%
1Y
-39.9%
CLASSYS
Market Cap: ₩3.7t
Provides medical aesthetics devices worldwide.
A214150
₩56,100.00
7D
20.3%
1Y
21.6%
ASTERASYSLtd
Market Cap: ₩556.6b
Manufactures and sells medical equipment for hospitals and skin care devices for beauty care clinics and salons in South Korea, Europe, Asia, the Middle East, Africa, North America, South America, Australia, and New Zealand.
A450950
₩14,840.00
7D
-3.9%
1Y
n/a